Cargando…
ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma
This study aimed to clarify the role of Orosomucoid 1 (ORM1) in the development and therapy resistance in hepatocellular carcinoma (HCC). The mRNA expression level of ORM1 was analyzed through integrative analysis of Gene Express Omnibus and The Cancer Genome Atlas datasets. The protein expression l...
Autores principales: | Gu, Jiangning, Xu, Shiqi, Chen, Xiang, Luo, Haifeng, Tan, Guang, Qi, Wenjing, Ling, Feng, Wang, Chenqi, Maimaiti, Feiliyan, Chen, Yunlong, Yang, Lili, Yin, Menghong, Chen, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589312/ https://www.ncbi.nlm.nih.gov/pubmed/35765957 http://dx.doi.org/10.17305/bjbms.2022.7268 |
Ejemplares similares
-
Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022) -
Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A meta-analysis
por: Chen, Yunlong, et al.
Publicado: (2021) -
Persistence in PHP with the doctrine ORM
por: Dunglas, Kévin
Publicado: (2013) -
Sulle orme di Carnot
por: Carrà, Sergio
Publicado: (2011) -
Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan
por: Chen, Wang-Qing, et al.
Publicado: (2013)